TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03448757

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: measuring hemodynamic parameters heart beat to heart beat during single-frequency exposure
Description: This study aims to create a method for non-invasive diagnosis of biofeedback effect exposure to LEEF modulated to specific frequencies in individuals exposed to hepatocellular carcinoma -specific frequencies in increasing sequential manner, frequency to frequency in patients with advanced hepatocellular carcinoma and healthy individuals.~Patients with advanced hepatocellular carcinoma will be exposed to specific LEEF-modulated frequencies (3 to 10 Hz difference) to identify the optimal frequency associated with greater response to the biofeedback effect in patients with advanced hepatocellular carcinoma.
Study: NCT03429062

Intervention type: OTHER
Intervention: Personal training exercises
Description: Personal training: strengthening, stretching, endurance, balance Whole body vibration: strengthening, balance, stretching, endurance, balance

Intervention type: OTHER
Intervention: Personal training exercises
Description: Personal training: strengthening, stretching, endurance, balance Whole body vibration: strengthening, balance, stretching, endurance, balance
Study: NCT00521092

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative study
Study: NCT02713048

Intervention type: OTHER
Intervention: Blood sample collection
Description: Eight blood samples in each patient within 48 hours to perform Troponin I measurement.

Intervention type: OTHER
Intervention: Blood sample collection
Description: Eight blood samples in each patient within 48 hours to perform Troponin I measurement.

Intervention type: OTHER
Intervention: Blood sample collection
Description: Eight blood samples in each patient within 48 hours to perform Troponin I measurement.
Study: NCT02732314

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Investigational OTC Cream

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cosmetic Eczema Cream

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.05% Desonide Cream

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Cream

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Cream
Study: NCT01094041

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gluten free diet
Description: A 4-week gluten free diet provided

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gluten rich diet
Description: A 4-week gluten rich diet is provided
Study: NCT00861458

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pharmacokinetics
Description: Single dose of 750 mg PF-00868554 as a solution and tablets.
Study: NCT04091152

Intervention type: OTHER
Intervention: usability assessment
Description: Usability of ardoiz will be assesse using a validated usability questionnary

Intervention type: OTHER
Intervention: usability assessment
Description: Usability of ardoiz will be assesse using a validated usability questionnary

Intervention type: OTHER
Intervention: usability assessment
Description: Usability of ardoiz will be assesse using a validated usability questionnary
Study: NCT03395639

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Edoxaban
Description: Edoxaban 15 mg or 30 mg tablets for participants 12 to \<18 years of age, or 60 mg edoxaban suspension (dosed as mg/kg) for participants under 12 years of age (and optionally, 12 or older), for oral administration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (SOC)
Description: Standard of care could include low molecular weight heparin (LMWH) and/or VKA according to the clinical site's SOC treatment regimen
Study: NCT01537731

Intervention type: PROCEDURE
Intervention: vaginal or laparoscopic hysterectomy
Description: vaginal hysterectomy or laparoscopic hysterectomy
Study: NCT03113526

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: remove drain
Description: remove drain when output is less than 30ml or less than 100ml per 24-hour

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: remove drain
Description: remove drain when output is less than 30ml or less than 100ml per 24-hour
Study: NCT03301818

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal tactile imager
Description: Patients will undergo elasticity assessment with vaginal tactile imaging the be once before surgical repair and twice after during a 3 month interval.
Study: NCT05892484

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thermal Imaging
Description: Thermal Imaging device used to evaluate fracture in those presenting with proposed wrist fracture in the emergency department.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: X-RAY
Description: Routine X-RAY
Study: NCT01546922

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrocortisone
Description: Patients receive either a low dose HC (0.2-0.3 mg/kg body weight) for 10 weeks followed by 10 weeks of high dose HC (0.4-0.6 mg/kg body weight) or vice versa.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrocortisone
Description: Patients receive either a low dose HC (0.2-0.3 mg/kg body weight) for 10 weeks followed by 10 weeks of high dose HC (0.4-0.6 mg/kg body weight) or vice versa.
Study: NCT01651611

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Description: The TTA will use motivational interviewing (MI) techniques to assess the participant's motivation and readiness to quit, suggest plans, and assist the participant in selecting a method of treatment.
Study: NCT03830879

Intervention type: OTHER
Intervention: No intervention
Description: This cohort study have any no intervention.
Study: NCT01651611

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling
Description: The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking cessation counseling
Description: The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Navigation to smoking cessation resources
Description: The TTA will assist participants in obtaining NRT and getting connected to smoking cessation counseling services, such as the Smokers' Quitline and clinic-based programs.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social support
Description: Meetings with the TTA will be a source of social support for the participant as they attempt to quit or stay quit.
Study: NCT02619682

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib Citrate
Description: Given PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study: NCT02867137

Intervention type: OTHER
Intervention: Blood sampling
Description: Blood sampling from peripheral venous catheter routinely inserted in trauma patients during transportation
Study: NCT01697644

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: somatropin
Description: 3 IU/m\^2/day. Dose adjusted approximately every 3 months. Injected subcutaneously once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: somatropin
Description: 3 IU/m\^2/day. Dose adjusted approximately every 3 months. Injected subcutaneously once daily
Study: NCT00468091

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: exendin(9-39)amide

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: exendin(9-39)amide

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: atropine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: atropine
Study: NCT01336179

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Salvadora persica
Description: twice daily use, two minutes interval

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Toothbrush
Description: Twice daily use two minutes interval
Study: NCT05818527

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acceledent vibrating device
Description: used to accelerated the movement of teeth during orthodontic treatment
Study: NCT00217867

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Animated character intervention with telephone follow-up
Description: Animated character will teach the discharge plan before discharge, then this teaching will be reinforced by computerized telephone system.
Study: NCT03298412

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Blinatumomab is administered as a continuous IV infusion.
Study: NCT01216592

Intervention type: OTHER
Intervention: COPD treatment
Description: Patients, will be asked to continue their previous medication (GOLD guidelines) during the study. No interventional change in COPD treatment will be performed during the study.
Study: NCT02619682

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study: NCT02187107

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TMC114
Description: 300 mg tablets of TMC114 ethanolate with microcrystalline cellulose, colloidal silicon dioxide, crospovidone, magnesium stearate, and Opadry® Orange

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rtv
Description: 100 mg tablet of Norvir®
Study: NCT02183584

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linagliptin
Study: NCT03838835

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Augmented equine-facilitated CBT group program
Description: Consists of CBT strategies including 1) providing psychoeducation about anxiety, 2) teaching coping strategies when anxious,and 3) identifying and addressing dysfunctional thoughts that maintain anxiety.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAU is equine-facilitated group therapy
Description: TAU is equine-facilitated group therapy at GallopNYC, which consists of horseback riding and integrates strategies to support the development of cognitive, physical, emotional, and social skills.
Study: NCT03444506

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Molo 1 (also referred as GSP 301-2 NS)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Molo 2 (also referred as GSP 301-1 NS)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo nasal spray

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DYMISTA nasal spray

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PATANASE nasal spray
Study: NCT02485444

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: 20 IU oxytocin in 500 ml normal saline will be infused 100 ml/h i.v. after fetus is delivered
Study: NCT03354039

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: DMD patients randomised to verum will receive 20 mg (0.6mg/kg) of Tamoxifen daily. Treatment will be given for the total period of 48 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Description: Patients randomised to placebo will be administered matching placebo. Treatment will be given for the total period of 48 weeks.
Study: NCT02061228

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pipelle de Cornier®
Description: Women in the intervention group will undergo an endometrial biopsy on the 6th day of ovarian stimulation using a Pipelle de Cornier® (CCD International, Paris, France). This class I individually and sterile-packaged medical device, complies with Directive 93/42/European Economic Community (EEC) and is routinely used in our centre for endometrial sampling. It is comprised of a flexible disposable polypropylene suction cannula with an outer diameter of 3.1 mm and a 2.4 mm diameter opening on the distal end, on one side of the cannula. An inner plunger creates a vacuum essential for the blind endometrial biopsy. After the introduction of the Pipelle into the uterine cavity, it will be rotated 360 degrees and moved up and down four times after withdrawing the piston.
Study: NCT02032329

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FastFES
Description: Fast treadmill walking supplemented with FES to ankle plantarflexor and dorsiflexor muscles, using a VFT stimulation pattern. 12 weeks of 2-3x/week. Stimulation delivered using the customKYnetics study device.
Study: NCT04014933

Intervention type: DIAGNOSTIC_TEST
Intervention: LASER SPECKLE FLOWGRAPHY
Description: Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region

Intervention type: DIAGNOSTIC_TEST
Intervention: LASER SPECKLE FLOWGRAPHY
Description: Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region

Intervention type: DIAGNOSTIC_TEST
Intervention: LASER SPECKLE FLOWGRAPHY
Description: Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region
Study: NCT02861937

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: non surgical periodontal therapy
Description: and root planing (SRP) was performed in two to four appointments lasting approximately 60 minutes each under local anaesthesia (2% lignocaine hydrochloride with 1:2,00,000 adrenaline) using area specific Gracey periodontal curettes and an ultrasonic device. The treatment was concluded in 3 weeks. Within the duration of the study, all subjects received supportive therapy, which included professional plaque control and reinstruction of oral hygiene.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: non surgical periodontal therapy
Description: and root planing (SRP) was performed in two to four appointments lasting approximately 60 minutes each under local anaesthesia (2% lignocaine hydrochloride with 1:2,00,000 adrenaline) using area specific Gracey periodontal curettes and an ultrasonic device. The treatment was concluded in 3 weeks. Within the duration of the study, all subjects received supportive therapy, which included professional plaque control and reinstruction of oral hygiene.
Study: NCT03178110

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical therapy and dynasplint
Description: Participants will receive a session of 30-45 minutes of manual therapy two times per week, for eight weeks. All participants will be instructed how to use the Dynasplint® Trismus System at home. Participants will start the use of the DTS for 10-30 minutes three times per day, every day. If the exercises are well tolerated, time will be progressively increased to 30 minutes and then intensity (force) will be increased.
Study: NCT02892968

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fascia-Iliaca Block(FIB)
Description: The target of the FIB is the potential space between the fascia iliaca and the iliacus muscle, at least 4 cm lateral to the Femoral artery. This is neither a drug nor a device.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Femoral Nerve Block(FNB)
Description: The target of the FNB technique is the intersection of the fascia iliaca and the femoral nerve. This is neither a drug nor a device.
Study: NCT02779608

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intraperitoneal docetaxel
Description: One peritoneal access port will be implanted in subcutaneous space of patients' abdominal wall after laparoscopic exploration.Then intraperitoneal docetaxel in 1litre normal saline will be administered through the port

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oral S-1
Description: 40mg/m² twice daily on day 1-14 every 3 weeks
Study: NCT02009839

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meeky Mouse program

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Computer Games
Study: NCT03969472

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: probiotics
Description: apply probiotic after operation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrophysiologic Therapy
Description: Pelvic floor electrophysiological therapy is used after surgery
Study: NCT00319436

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentalizing Therapy for Substance Using Mothers
Description: This 12 session individual therapy aims to enhance maternal reflective functioning and soften harsh and distorted mental representations about the child. The intervention adopts a developmental progression based on attachment theory, supporting the mother in her parenting role and offering assistance with basic needs. Mothers are encouraged to reflect on their thoughts and feelings and how they affect behavior. The therapist assists mother's thinking about representations of herself as a parent and encourages her to explore opportunities for new understanding of her emotional needs. Therapist and mother explore representations of her child and their relationship in detail in order to understand their meaning and promote more balanced representations and affect regulation. Therapist and mother also explore child's emotional experiences underlying behavior. The goal is to support the mother in becoming more aware of her child's emotional needs.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Parent Education for Substance Using Mothers
Description: This 12 session comparison was designed to match the experimental intervention on time spent with the counselor and maternal expectations for help with parenting. PE counselors helped mothers get connected to services (e.g. medical and pediatric care, child guidance services, housing assistance, vocational training), solve problems of daily living and make parenting-related decisions. PE mothers also received a pamphlet each week on a parenting topic of their choice. Pamphlets focused on common issues in caring for infants (e.g., soothing a crying baby, managing bedtime routines, and establishing routines ) and toddlers (e.g., helping toddlers dress, managing bedtime battles, managing difficult behavior in public, and setting limits without using punishment). Pamphlets provided behavioral guidance at a 5th grade reading level without reference to underlying mental states or emotional needs.
Study: NCT01979393

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study: NCT03897348

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 100 mg
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 100 mg
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 100 mg
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 100 mg
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 200 mg
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 200 mg
Description: Oral medication
Study: NCT01622920

Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound transducer
Description: A hand-held ultrasound transducer will be placed on a central incisor and enamel thickness measurements recorded
Study: NCT02215421

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mommio
Description: The objective is to build parent's skills in encouraging their child to eat vegetables. The player is asked to read a novella, Totally Frobisher (providing backstory to the game), and play a game called Mommio (a casual video game for parents of 3 to 5 year old children). The player calls Kiddio, the child character, to dinner, and offers a vegetable (V) (selected from among several). Kiddio refuses. The player is offered a selection of V parenting statements (from the scientific literature on food parenting) or manipulation of the environment (e.g. turning off the kitchen TV) to control the situation and encourage the child to eat the V. As problems arise (e.g. a permissive father saying he doesn't like vegetables), the player must select ways to cope. Players set a goal to do with their child at home what they learned in the game. Game episodes include food store shopping, eating in the car, at grandma's, and at a fast food store.
Study: NCT02523664

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrocortisone
Description: effects of hydrocortisone on memory while fMRI
Study: NCT03897348

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 200 mg
Description: Oral medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 200 mg
Description: Oral medication
Study: NCT02110056

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: tDCS
Description: transcranial direct current stimulation (tDCS)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: transcranial direct current stimulation (tDCS)

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: training
Description: intensive training of visual-spatial abilities (in LOCATO task)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: training
Description: intensive training of visual-spatial abilities (in LOCATO task)
Study: NCT00892593

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Testing
Description: Fecal Immunochemical Testing is a stool test specific for human hemoglobin.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Testing
Description: Fecal Immunochemical Testing is a stool test specific for human hemoglobin.
Study: NCT01785004

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 (cholecalciferol), 2000 IU per day
Description: cholecalciferol

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3 (cholecalciferol), 2000 IU per day
Description: cholecalciferol

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin D3 (cholecalciferol), 2000 IU per day
Description: cholecalciferol

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: omega-3 fatty acids (fish oil)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: omega-3 fatty acids (fish oil)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: omega-3 fatty acids (fish oil)